VIMTALABS / guidance tracker

Keep management guidance in view.

Vimta Labs · forward-looking guidance across the available source record.

Research layer active

Guidance tracker

What management said would happen.

Target 20-25% revenue CAGR

Management targets maintaining historical CAGR of 20-25% annually, aiming for ₹500 crore revenue run-rate.

growth

EBITDA margin to remain around 35%

Management expects EBITDA margin to sustain in the 35% range, with possible 1-2% correction due to input cost and manpower inflation.

margins

Biologics CRD to start in FY27

Infrastructure and team are ready; initial projects expected from domestic clients, with international traction building.

expansion